Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
- 1 August 2018
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 24 (8), 865-870
- https://doi.org/10.1016/j.cmi.2017.11.020
Abstract
No abstract availableKeywords
Funding Information
- European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
This publication has 6 references indexed in Scilit:
- Colistin Is Extensively Lost during Standard In Vitro Experimental ConditionsAntimicrobial Agents and Chemotherapy, 2017
- Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolatesJournal of Antimicrobial Chemotherapy, 2017
- Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2015
- Susceptibility Testing of the Polymyxins: Where Are We Now?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative BacilliJournal of Clinical Microbiology, 2013
- Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistinDiagnostic Microbiology and Infectious Disease, 2012